SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-010370
Filing Date
2024-07-30
Accepted
2024-07-30 15:55:22
Documents
15
Period of Report
2024-07-24
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20240724x8k.htm   iXBRL 8-K 50591
2 EX-99.1 glyc-20240724xex99d1.htm EX-99.1 23782
3 GRAPHIC glyc-20240724xex99d1001.jpg GRAPHIC 5797
  Complete submission text file 0001558370-24-010370.txt   210423

Data Files

Seq Description Document Type Size
4 EX-101.SCH glyc-20240724.xsd EX-101.SCH 3510
5 EX-101.LAB glyc-20240724_lab.xml EX-101.LAB 15361
6 EX-101.PRE glyc-20240724_pre.xml EX-101.PRE 10380
17 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20240724x8k_htm.xml XML 4658
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 241157198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)